Brain scans aim to unlock secrets of long COVID
NCT ID NCT07527130
First seen Apr 25, 2026 · Last updated May 14, 2026 · Updated 3 times
Summary
This study uses a special PET scan with an investigational drug called C-11 ER176 to look for signs of inflammation in the brains of people with Post-COVID Syndrome (Long COVID). Researchers hope to learn more about what causes ongoing symptoms after a COVID-19 infection. The study will involve 10 Mayo Clinic patients who have had COVID-19 and are experiencing long-term effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.